| Send2Press.com • Today is Friday, May 24, 2013 | A Member of the Neotrope News Network |  |
|
|
Send2Press : U.S. and World News :
Advertising and Marketing
: Eularis Updates Reports That Help Pharmaceutical Companies Do More for Real Growth Than Simply Downsizing
Press Release:
Eularis Updates Reports That Help Pharmaceutical Companies Do More for Real Growth Than Simply Downsizing
 New techniques and tools to provide actual growth for pharmacos showcased in Eularis' updated reports.LONDON, U.K., April 5 (SEND2PRESS NEWSWIRE) -- The pharmaceutical industry is facing unprecedented challenges on many fronts - a slew of patient expiries, a lack of blockbusters in the pipeline to replace the patent expiries, decreasing growth in many major markets, generic competition, constantly changing regulatory and competitive environment rendering old tools for analysis obsolete, increased pressure on CEOs to deliver shareholder growth resulting in budget cuts, downsizing, and less than optimal results. Therefore, given these challenges, today is the worst time in the history of pharmaceuticals to be a pharmaceutical marketer. Eularis has updated its reports that focus on specific key issues for pharma marketers that help them understand how to handle these specific situations. These reports uncover practices to predict how and where pharmaceutical marketing and sales investments will yield the highest market share and market share price and highlight real life case studies. Readers will benefit from the step-by-step guidelines on successfully implementing approaches for real and measurable results available only in these reports. Details about these updated reports can be found at: www.ePharmaROI.com : How to Harness the Power of Social Media in Pharmaceutical eMarketing. www.pharmaprelaunchroi.com : Pre-Launch Planning: Priming your Pharmaceutical Brand for Profit and Success. www.GenericsDefenseStrategies.com : How to Plan an Effective Generics Defense Strategy: Planning, Tactics and Implementation. www.PatientAdherenceROI.com : Ensuring Profitable Patient Adherence Programs: Using Analytics and Metrics to Improve the Bottom Line www.PharmaIndustrySFE.com : Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? www.PharmaMarketingROI.com : Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line. www.epharmaroi.com : How To Harness The Power Of Social Media In Pharmaceutical eMarketing. About Eularis: Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches, whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate and optimize their sales and marketing performance. The company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others. For more information about Eularis, visit www.eularis.com.
NEWS SOURCE: Eularis
Canonical Permalink for This Press Release: http://www.send2press.com/newswire/2010-04-0405-003.shtml
Send2Press® is the originating wire service for this story. Terms of Use. © Eularis. All trademarks acknowledged.
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE ("Eularis"), WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE.
Journalist Resources:
Download original press release as issued including media contact information for Eularis.
Additional News Releases on Similar Topics:
|
Additional Press Releases from Eularis :
» MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London » Eularis Analyzes Pre-Launch Brand Planning with New Pharmaceutical Industry Report
JOURNALISTS & WRITERS:
Subscribe to Send2Press® Daily News Summary by E-Mail
Follow Send2Press on Social Sites: 
|
||||||||||||||||||||||
View our news channels by industry topics, by U.S. States, or by selected U.S. Cities:
|
Terms of Use and License
This "article format" version of the issued press release is Copr. © 1983-2013 Neotrope/Send2Press. You may freely link to this article version of the press release or may use the release text as the basis for an original article or news posting. If the content is copied verbatim via a scraping or copy/paste method, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story (may not be posted on ANY site selling/offering marketing services, newswire services, or adult content!). |
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the source. The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this website) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Eularis Updates Reports That Help Pharmaceutical Companies Do More for Real Growth Than Simply Downsizing, pharmaceutical industry, Eularis, pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions, ROI, 94.8 Analytics Process, How To Harness The Power Of Social Media In Pharmaceutical eMarketing, press release, Apr 5, 2010. |
|
THIS PAGE MEDIA READS (by media and public, as of today): 3999 times (3 today, 30 this week, 121 this month, 608 this year)
Site Design and Content is Copr. © 1983 - 2013 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Targeted Press Release Distribution Services | Press Release Writing Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Journalist Tools | Client eMediaKits | Daily News Desk | Success Stories | Online Newswire Service | Internet Marketing Services | Order PR Services | Terms of Service (TOS)